Lotus Bio-Technology Development Corp. announced earnings results for the third quarter ended December 31, 2017. For the third quarter, the company announced operating loss was USD 622 compared to USD 18,031 a year ago. Net loss was USD 622 compared to USD 18,031 a year ago. For the nine months, operating loss was USD 15,983 compared to USD 22,652 a year ago. Net loss was USD 15,983 compared to USD 22,652 a year ago.